Table 1 Antitumor reactivity of... | American Society of Hematology

Table 1

Antitumor reactivity of individual γ9δ2T-cell clones

	αβ T cells	γ9δ2 bulk	γ9δ2 cl3	γ9δ2 cl4	γ9δ2 cl5	γ9δ2 cl7	γ9δ2 cl8	γ9δ2 cl13	γ9δ2 cl15
PBMCs	3*	2*	10*	2*	7*	0*	3*	12*	13*
K562	0*	14*	9*	9*	62†	181‡	7*	56†	12*
Daudi	0*	206‡	211‡	55†	458‡	318‡	268‡	500‡	244‡
MZ1851RC	0*	205‡	4*	94†	114‡	216‡	77†	93†	19*
BT549	0*	2*	1*	0*	44†	1*	2*	41†	8*
MCF-7	0*	2*	6*	1*	64†	1*	1*	58†	10*
SW480	0*	0*	11*	2*	3*	1*	1*	4*	11*
MDA MB 231	0*	4*	2*	1*	12*	1*	1*	14*	10*

	αβ T cells	γ9δ2 bulk	γ9δ2 cl3	γ9δ2 cl4	γ9δ2 cl5	γ9δ2 cl7	γ9δ2 cl8	γ9δ2 cl13	γ9δ2 cl15
PBMCs	3*	2*	10*	2*	7*	0*	3*	12*	13*
K562	0*	14*	9*	9*	62†	181‡	7*	56†	12*
Daudi	0*	206‡	211‡	55†	458‡	318‡	268‡	500‡	244‡
MZ1851RC	0*	205‡	4*	94†	114‡	216‡	77†	93†	19*
BT549	0*	2*	1*	0*	44†	1*	2*	41†	8*
MCF-7	0*	2*	6*	1*	64†	1*	1*	58†	10*
SW480	0*	0*	11*	2*	3*	1*	1*	4*	11*
MDA MB 231	0*	4*	2*	1*	12*	1*	1*	14*	10*

INFγ spots/15 000 cells < 40.

IFNγ spots/15 000 cells 40-100.

IFNγ spots/15 000 cells >100.